Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
NEW YORK, April 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
BRICSS Market Watch:
The broad 'health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
BRICSS peripheral vascular devices segment forecasts to reach at US$0.9 billion by 2015 at a CAGR of 10.5% during the analysis period 2009-2015. China accounts for nearly 30% of the global value and India claims more than 20% of the market. In terms of CAGR, India is the fastest growing regions while China and South Korea are just behind.
Among the product types, peripheral vascular stents accounts for more than 30% while PTA Balloon catheters and Aortic Stent Graft claim second and third largest portions, respectively. Forecasts of BRICSS retrievable IVC filters market value indicate a close to 50% of the IVC segment by 2015 leaving the rest of the market to the permanent filters. While considering EPD segment, forecasts for balloon occlusion types indicate a close 47% of the market value while catheters occlusion devices account for nearly 40%.
Report Focus:
The report 'Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in cardiac peripheral vascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.
The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand Of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies
The report covers the market analysis by product types.
The subdivisions are as:
Peripheral Vascular Devices
1. Peripheral Vascular Stents
2. PTA Balloon Catheters
3. Aortic Stent Graft
4. Inferior Vena Cava (IVC) Filters
a. Retrievable Filters
b. Permanent IVC Filters
5. Embolic Protection Devices (EPD)
a. Balloon Occlusion Devices
b. Catheter Occlusion Devices
c. Filter Devices
6. Peripheral Guidewires
7. Synthetic Surgical Grafts
8. Others
The period considered for the market analysis is 2009-2015. The region wise distribution of the market consists of Emerging Markets Brazil, Russia, India, China, South Africa and South Korea. Incorporating the recession impacts on the industry, the market growth rate in these economies are estimated individually for the upcoming years.
More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 108 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry.
I. REPORT FOCUS
A. INTRODUCTION
BRADYCARDIA
SENSOR EXPERTISE WILL URGE DEVELOPMENT IN PACEMAKER MARKET
PROGRESS OF RATE-RESPONSIVE PACEMAKERS WITH SEVERAL SENSORS - INDUSTRY OVERVIEW
TACHYCARDIA
CARDIOPULMONARY (CPB)
A DEVICE IDENTIFIES PATIENTS RISK
B. PERIPHERAL VASCULAR DEVICES
DIAGNOSIS
EPIDEMIOLOGY
PERIPHERAL VASCULAR STENTS
AORTIC STENT GRAFT
STENT GRAFTS (AORTIC ANEURYSMS)
PTA BALLOON CATHETERS
PTA BALLOON CATHETER FOR HIGH PRESSURE DILATION PROCEDURES
INFERIOR VENA CAVA (IVC) FILTERS
IVC FILTER BRANDS
GREENFIELD FILTER
A. RETRIEVABLE FILTERS
B. PERMANENT IVC FILTERS
EMBOLIC PROTECTION DEVICE (EPD)
A. BALLOON OCCLUSION DEVICES
B. CATHETER OCCLUSION DEVICES
C. FILTER DEVICES
SYNTHETIC SURGICAL GRAFTS
VASCULAR GRAFTING
ARTHERECTOMY DEVICES
AV ACCESS THROMBECTOMY DEVICES
IDEAL THROMBECTOMY DEVICES
MECHANICAL THROMBECTOMY DEVICES FOR TREATING ACUTE PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
ADVANTAGES:
DISADVANTAGES:
C. A REVIEW ON CARDIAC DISEASES
CARDIOVASCULAR DISEASES
CARDIOVASCULAR DISEASE STATISTICS
MORTALITY FROM MAJOR CARDIOVASCULAR DISEASES: UNITED STATES
RHEUMATIC HEART DISEASE
RHEUMATIC HEART DISEASE STATISTICS
CORONARY ARTERY DISEASE (CAD) OR CORONARY HEART DISEASE (CHD)
CORONARY ARTERY DISEASE (CAD) STATISTICS
CEREBROVASCULAR DISEASE – STROKE
PERIPHERAL VASCULAR DISEASE (PVD)
PERIPHERAL VASCULAR DISEASE (PVD) – EPIDEMIOLOGY
PERIPHERAL VASCULAR DISEASE (PVD) – SCREENING
VALVULAR HEART DISEASE
DIAGNOSIS
HYPERTENSIVE HEART DISEASE
CONGESTIVE HEART FAILURE (CHF)
INCIDENCE AND PREVALENCE
FACTS ABOUT CHF
ARTRIAL FIBRILLATION (AF)
ARTRIAL FIBRILLATION (AF) - EPIDEMIOLOGY
ISCHAEMIC HEART DISEASE
INFLAMMATORY HEART DISEASE
HEART ATTACK AND ANGINA STATISTICS
STROKE STATISTICS
D. PERIPHERAL VASCULAR DEVICES - TYPES - MARKET BRIEFING
CHINA
INDIA
BRAZIL
RUSSIA
SOUTH KOREA
SOUTH AFRICA
E. INFERIOR VENA CAVA (IVC) FILTERS - TYPES - MARKET BRIEFING
CHINA
INDIA
BRAZIL
RUSSIA
SOUTH KOREA
SOUTH AFRICA
F. EMBOLIC PROTECTION DEVICES (EPD) - TYPES - MARKET BRIEFING
CHINA
INDIA
BRAZIL
RUSSIA
SOUTH KOREA
SOUTH AFRICA
II. MARKET ANALYSIS
PERIPHERAL VASCULAR DEVICES – BRICSS – INDUSTRY SNAPSHOT
A. PERIPHERAL VASCULAR DEVICES – SEGMENTATION
PERIPHERAL VASCULAR DEVICES – GLOBAL
PERIPHERAL VASCULAR DEVICES – BRICSS
PERIPHERAL VASCULAR DEVICES – BY TYPE
PERIPHERAL VASCULAR DEVICES – BRICSS
PERIPHERAL VASCULAR STENTS
PTA BALLOON CATHETERS
AORTIC STENT GRAFT
INFERIOR VENA CAVA (IVC) FILTERS
INFERIOR VENA CAVA (IVC) FILTERS – BY TYPE
INFERIOR VENA CAVA (IVC) FILTERS - TYPES – BRICSS
RETRIEVABLE FILTERS
PERMANENT IVC FILTERS
EMBOLIC PROTECTION DEVICES (EPD)
EMBOLIC PROTECTION DEVICES (EPD) – BY TYPE
EMBOLIC PROTECTION DEVICES (EPD) - TYPES – BRICSS
BALLOON OCCLUSION DEVICES
CATHETER OCCLUSION DEVICES
FILTER DEVICES
PERIPHERAL GUIDEWIRES
SYNTHETIC SURGICAL GRAFTS
OTHER PERIPHERAL VASCULAR DEVICES
B. GROWTH RATE ANALYSIS
BRICSS PERIPHERAL VASCULAR STENTS MARKET GROWTH RATES
PERIPHERAL VASCULAR DEVICES MARKET – TYPES
BRICSS PERIPHERAL VASCULAR DEVICES TYPES - GROWTH RATES
INFERIOR VENA CAVA (IVC) FILTERS MARKET – TYPES
BRICSS INFERIOR VENA CAVA (IVC) FILTERS MARKET GROWTH RATES
EMBOLIC PROTECTION DEVICES (EPD) MARKET – TYPES
BRICSS EMBOLIC PROTECTION DEVICES (EPD) MARKET GROWTH RATES
C. INVESTMENT FOCUS
III. GLOBAL CARDIAC MEDICAL DEVICES INDUSTRY OVERVIEW
FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS
IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS
A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
1. CARDIAC RHYTHM MANAGEMENT DEVICES
CRM IN EUROPE
CARDIAC DEFIBRILLATORS
RAPID GROWTH IN DEFIBRILLATOR SALES
CARDIAC PACEMAKER DEVICES
STATISTICS ON PACEMAKERS AND IMPLANTABLE CARDIAC DEVICES PRESENTED AT EUROPACE 2009
THE DATA COLLECTION WORK
CARDIAC RESYNCHRONIZATION THERAPY (CRT)
2. CARDIAC MONITORING AND DIAGNOSTIC DEVICES
THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE
HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW
3. INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION
CARDIAC CATHETERS
COMPETITIVE ANALYSIS
INTRAVASCULAR ULTRASOUND CATHETERS (IVUS)
GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS
ARTERIOTOMY CLOSURE DEVICES
4. PERIPHERAL VASCULAR DEVICES
EMBOLIC PROTECTION DEVICES (EPD)
INFERIOR VENA CAVA (IVC) FILTERS
CONCLUSION
PERIPHERAL GUIDEWIRES
AV ACCESS THROMBECTOMY DEVICES
5. CARDIAC PROSTHETIC DEVICES
6. ELECTROPHYSIOLOGY CATHETERS (EP)
GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH
EP MAPPING
NEW AF ABLATION DEVICES SEEK APPROVAL
ATRIAL FIBRILLATION (AF)
SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
MARKET CHALLENGES
B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
SIZE AND WEIGHT
POWER EFFICIENCY
PERFORMANCE SPECIFICATIONS
RISK MITIGATION AND RELIABILITY
C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
IMPACT OF CVD IN EUROPE
IMPACT ON NEW YORK STATE
ECONOMIC IMPACT OF CVD IN NYS
HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
IMPACT OF CVD ON ECONOMIC STABILITY
ECONOMIC COST OF CARDIOVASCULAR DISEASES
COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030
CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE
D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND
E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES SEGMENT
CARDIOVASCULAR MEDICAL DEVICE APPROVALS – IN DETAIL
F. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/ETC……
EDWARDS LIFESCIENCES' REDESIGNED TRANSCATHETER HEART VALVE SAPIEN XT SHOWS IMPROVEMENTS
PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
PHILIPS LAUNCHES THREE NEW IMAGING SYSTEMS
IRHYTHM PUBLISHES ZIO® PATCH STUDY RESULTS DEMONSTRATING SUPERIOR ABILITY TO DETECT AF
SUPERSONIC IMAGINE UNVEILS AIXPLORER® ERGONOMICS AND ULTRAFAST™ PLATFORM
ROYAL PHILIPS HEALTHCARE AND INFRAREDX LAUNCH SOLUTION FOR SEAMLESS INTEGRATION OF TVC IMAGING SYSTEM WITH PHILIPS' ALLURA XPER SYSTEMS
MERIT MEDICAL RECEIVES CE MARKING FOR EMBOSPHERE(R)
CARDIONET ANNOUNCES PARTNERSHIP WITH IMEC AND HOLST CENTRE FOR NEXT GENERATION CARDIAC MONITORING PRODUCTS
INVENTIV HEALTH CLINICAL NAMED "CLINICAL COMPANY OF THE YEAR"
NANO-MATERIALS VITAL IN DEVELOPING TOUGHER ARTIFICIAL HEARTS
VOLCANO INTRODUCES LATEST IPAD TEACHING SOLUTION FOR ITS NEWLY-RELEASED VISIONS® PV .035 DIGITAL IVUS CATHETER
CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
WELCH ALLYN TO DISTRIBUTE EARLYSENSE PATIENT MONITORING SYSTEM IN US
JLL PARTNERS SIGNS AGREEMENTS TO ACQUIRE BIOCLINICA AND CORELAB PARTNERS
SANOFI UNVEILS PATH BREAKING TECHNOLOGY FOR CARDIOVASCULAR AND VASCULAR SURGERY PROCEDURES
MEDTRONIC FINISHES SE STENT ACQUIRES CE MARK FOR APPLICATION IN LOWER EXTREMITIES
ANGIOSCORE PRESENTS NEW SIZE OF ANGIOSCULPT PTA SCORING BALLOON CATHETERS
ON-X LIFE TECH INTRODUCES LATEST HEART VALVE REPLACEMENT DEVICE
BIOSENSORS ACQUIRES CE MARK SANCTION FOR BIO-FREEDOM™
MEDTRONIC FINISHES PATIENT ENROLLMENT FOR IN.PACT ADMIRAL DRUG-ELUTING BALLOON STUDY
BIOTRONIK BEGINS MATRIX STUDY FOR IMPROVED DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION
DEFIBETCH'S LIFELINE PRO AND LIFELINE ECG AEDS ACHIEVE FDA CLEARANCE
ABBOTT POSTS LAST-QUARTER AND FULL-YEAR 2012 OUTCOMES
ST JUDE MEDICAL OBTAINS CE MARK FOR AMPLATZER AMULET LEFT ATRIAL APPENDAGE OCCLUDER
NCONTACT GETS FDA CLEARANCE FOR EPI-SENSE CARDIAC ABLATION DEVICE WITH EMBEDDED SENSORS
PHILIPS PRESENTS ADVANCED EP NAVIGATOR AT BOSTON AF SYMPOSIUM
ST JUDE MEDICAL GETS CE MARK APPROVAL FOR VIEWFLEX XTRA ICE CATHETER
BOSTON SCIENTIFIC ZERO AF TRIAL TREATS FIRST PATIENT TO EVALUATE BLAZER OPEN-IRRIGATED CATHETERS
DEFIBTECH'S LIFELINE AUTO AUTOMATIC EXTERNAL DEFIBRILLATOR CLEARED FOR SALE IN THE US
NOVATION OPTS FOR NIHON KOHDEN PERMANENT VITAL SIGNS MONITORING SYSTEM
ST. JUDE'S REMOTE MONITORING SYSTEM ACQUIRES FDA SANCTION
ST. JUDE POSTS PRELIM 4Q RESULTS
AMBIO DISPLAYS REMOTE HEALTH MONITORING SYSTEM
MICROSEMI'S LATEST RF MODULES SPEED TIME-TO-MARKET FOR IMPLANTABLE MEDICAL DEVICE DESIGNERS
ABBOTT'S ABSORB BVS EVALUATED FOR TREATMENT OF CAD AT CHRIST HOSPITAL
ABBOTT INITIATES ABSORB III CLINICAL TRIAL IN THE UNITED STATES
CARDIAC SCIENCE TO DELIVER POWER-HEART G3 AEDS TO CHICAGO METRA
ABBOTT RECEIVES FDA APPROVAL FOR NEXT-GENERATION XIENCE XPEDITION™ DRUG ELUTING STENT SYSTEM
FDA 515I RECLASSIFICATION PANEL ENDORSES CLASS III STATUS FOR TEMPORARY VENTRICULAR SUPPORT DEVICES IN THE NON-ROLLER TYPE CARDIOPULMONARY BYPASS BLOOD PUMPS CATEGORY
BIOTRONIK HOME MONITORING® REDUCES INAPPROPRIATE ICD SHOCKS BY 52% - ECOST TRIAL RESULTS
CARDIACASSIST BEGS FDA'S APPROVAL FOR TANDEMHEART CLINICAL STUDY
BOSTON SCIENTIFIC STARTS CLINICAL TRIAL OF INGEVITY™ PACING LEADS
CARDIOMEMS TO CREATE WIRELESS SENSORS BASED PATIENT-MONITORING DEVICE FOR CARDIAC DISEASES
THORATEC REPORTS APPROVAL FOR HEARTMATE II® IN JAPAN
GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
SORIN GROUP ANNOUNCES FIRST PARADYM™ RF IMPLANT AND SMARTVIEW™ REMOTE MONITORING IN NORTH AMERICA
EDWARDS LIFESCIENCES FORECASTS STRONG GROWTH IN SALES AND EARNINGS IN 2013
SORIN GROUP INTRODUCES FIRST PARADYM™ RF IMPLANT AND PRIMARY SMARTVIEW™ REMOTE MONITORING STIMULATED PATIENT IN NORTH AMERICA
SORIN GROUP RECEIVES PMDA APPROVAL AND ANNOUNCES COMMERCIAL LAUNCH OF THE MITROFLOW® AORTIC PERICARDIAL HEART VALVE IN JAPAN
SORIN GROUP RECEIVES PMDA APPROVAL FOR THE MITROFLOW®AORTIC PERICARDIAL HEART VALVE IN JAPAN; COMMERCIAL LAUNCH ANNOUNCED.
VOLCANO CORPORATION INKS AGREEMENT TO ACQUIRE CRUX BIOMEDICAL
IMPEDANCE CARDIOGRAPHY SET TO REPLACE HUT FOR VASOVAGAL SYNCOPE DIAGNOSIS
EDWARDS LIFESCIENCES RECEIVES CHINA'S SFDA APPROVAL FOR PERIMOUNT MITRAL HEART VALVE
GE HEALTHCARE DEVELOPS SOLUTIONS TO ENHANCE THE CT APPLICATIONS
UNIVERSITY OF WISCONSIN AND GE HEALTHCARE GET INTO AN AGREEMENT FOR PROTOCOLS TO ENHANCE DISEASE DIAGNOSIS
BIOTRONIK STUDY TO ASSESS INNOVATIVE INTRACARDIAC IMPEDANCE SENSING TECHNOLOGY FOR CRT OPTIMIZATION
MERIT MEDICAL SIGNS AGREEMENT TO ACQUIRE THOMAS MEDICAL PRODUCTS FROM GE HEALTHCARE
AGFA HEALTHCARE SIGNS DISTRIBUTION AGREEMENT WITH GULF MEDICAL
ST. JUDE MEDICAL ANNOUNCES FIRST PORTICO TRANSCATHETER AORTIC HEART VALVE IMPLANTATION USING TRANSAPICAL DELIVERY SYSTEM
SORIN GROUP ADVANCES IN HIGHLIFE, A EXPANSION-LEVEL COMPANY AIMED FOR PERCUTANEOUS MITRAL VALVE TRANSPLANT SYSTEM
VOLCANO SIGNS DEFINITIVE AGREEMENT TO ACQUIRE SYNC-RX LTD
ECARDIO UNVEILS INSTRUCTIONAL PATIENT VIDEO SERIES TO ENHANCE MONITORING EXPERIENCE
HEARTWARE ACHIEVES FDA APPROVAL FOR HEARTWARE® VENTRICULAR ASSIST SYSTEM AS A BRIDGE TO HEART TRANSPLANTATION FOR PATIENTS WITH END-STAGE HEART FAILURE
ST. JUDE MEDICAL ACHIEVES CE MARK APPROVAL FOR PORTICO TRANSCATHETER AORTIC HEART VALVE
BIOTRONIK'S NEW EVIA HF-T CRT PACEMAKER IMPLANTED IN THE FIRST 34 US PATIENTS
COOK MEDICAL BEGS FDA'S APPROVAL FOR ZILVER PTX
COOK MEDICAL SIGNS CONTRACT WITH NOVATION FOR PERIPHERAL VASCULAR PRODUCTS
COOK MEDICAL BEGS FDA'S MARKETING APPROVAL FOR ZILVER® PTX®
BIOTRONIK UNVEILS 3FLOW ASPIRATION CATHETER FOR IMPROVED THROMBUS ASPIRATION.
SORIN GROUP ACQUIRES NEUROTECH.
HEARTWARE RELEASES THIRD QUARTER 2012 RESULTS
CAL FIRE AND CCGA DEPLOY ZOLL'S NEW VERSION OF POCKETCPR
SORIN GROUP DECLARES U.S INTRODUCTION OF NEW HEART DEVICE FOR SIMULTANEOUS IMPLANTATION OF AN AORTIC TISSUE VALVE AND ASCENDING AORTA
ST. JUDE MEDICAL UNVEILS ITS MEDIGUIDE TECHNOLOGY
LIDCO LAUNCHES LIDCORAPID V2 AT ESICM AND ASA
NIHON KOHDEN TO PURCHASE DEFIBTECH (U.S. COMPANY)
ASAHI KASEI ZOLL A JAPANESE SUBSIDIARY ESTABLISHED BY ZOLL® MEDICAL CORPORATION
C. R. BARD ACQUIRES NEOMEND
K-TUBE TECHNOLOGIES JOINS HAND WITH MER-EUROPE AND MEDICAL METALS
STENTYS RECEIVES IDE APPROVAL FROM THE FDA TO CONDUCT THE FIRST U.S. CLINICAL TRIAL WITH SELF-APPOSING® STENT
RE -REGISTRATION OF MUSTANG® CORONARY STENT SYSTEM SUCCESSFULLY BY SFDA.
EDWARDS LIFESCIENCES' TRANSCATHETER VALVE RECEIVES EXPANDED INDICATION FROM FDA
ST. JUDE MEDICAL REVIEW
ENDOLOGIX FINALIZES PATENT LITIGATION WITH COOK MEDICAL
CATHRX SIGNS MANUFACTURE AND SUPPLY AGREEMENT WITH GMMI SDN BHD
ZOLL AND GS GMBH CREATE LICENSING AGREEMENT TO INCORPORATE REAL CPR HELP IN CORPULS DEFIBRILLATORS
U.S. PATENT AND TRADEMARK OFFICE HAVE AWARDED POSITRON A PATENT FOR SOLID STATE SENSORS.
INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
BIOTRONIK LAUNCHES IMPLANTABLE BIOMONITOR®, WHICH HAS THE HIGHEST PRECISION IN MONITORING ARRHYTHMIAS
EDWARDS LIFESCIENCES ACQUIRES BMEYE
VOLCANO LAUNCHES PRIMEWIRE PRESTIGE® PLUS PRESSURE GUIDE WIRE WITH ACUSENSE™ TECHNOLOGY
COOK MEDICAL GAINS HEALTH CANADA APPROVAL FOR ITS ZILVER VENA STENT
VOLCANO RECEIVES CE MARK AND 510(K) CLEARANCE FOR NEW VISIONS® PV .035 DIGITAL IVUS CATHETER
BOSTON SCIENTIFIC LAUNCHES PROMUS ELEMENT™ STENT
TERUMO BROADENS LICENSING AGREEMENT WITH BIOSENSORS TO SELL NOBORI® DES SYSTEM INCORPORATING BIOMATRIX™ TECHNOLOGY
MALLINCKRODT ACQUIRES CNS THERAPEUTICS
CARDIAC SCIENCE LAUNCHES WEARABLE BURDICK® 4250 HOLTER RECORDER
COVIDIEN LAUNCHES SONICISION™ CORDLESS ULTRASONIC DISSECTION DEVICE AND IDRIVE™ ULTRA POWERED STAPLING SYSTEM AT ACS
ESTECH RELEASED THE COBRA FUSION™ SYSTEM FOR CARDIAC ABLATION
BIOTRONIK INTRODUCES PULSAR-35 SELF-EXPANDING STENT AND PASSEO-14 PTA BALLOON CATHETER
TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
STENTYS LAUNCHES NEW STENT-DELIVERY SYSTEM TO ALLOW IMPLANTATION IN COMPLEX VESSEL ANATOMIES.
MALLINCKRODT SIGNS DEFINITIVE AGREEMENT TO ACQUIRE CNS THERAPEUTICS
BOSTON SCIENTIFIC OBTAINS BRIDGE-POINT MEDICAL TO BOLSTER INTERVENTIONAL CARDIOLOGY BUSINESS
SORIN GROUP ACQUIRES SFDA SANCTION AND DECLARES COMMERCIAL LAUNCH OF REPLY™ AND ESPRIT™ FAMILIES OF PACEMAKERS IN CHINA
FDA SANCTIONS REMOTE CARDIAC ARRHYTHMIA MONITOR
VIRTUOSAPH® PLUS ENDOSCOPIC VESSEL HARVESTING SYSTEM FROM TERUMO OFFERS CARDIAC SURGERY TEAM WITH CONTROL, CONSISTENCY AND CONFIDENCE
ENDOLOGIX ACHIEVES CE MARK FOR NELLIX(R) ENDOVASCULAR ANEURYSM SEALING SYSTEM
BOSON BIOTECH COMPLETES CE REGISTRATION OF OVER FORTY PRODUCTS.
POSITRON & JUBILANT DRAXIMAGE APPROVES FOR A STRATEGIC COLLABORATION FOR SR-82/RB-82 GENERATORS.
MILLAR INSTRUMENTS COMPLETES MERGER WITH TELEMETRY RESEARCH.
STEMI ALERT SMARTPHONE APP - A LIFESAVER.
ABBOTT OBTAINS FDA APPROVAL FOR OMNILINK ELITE® VASCULAR BALLOON-EXPANDABLE STENT SYSTEM FOR TREATMENT OF ILIAC ARTERY DISEASE
BIOTRONIK LUMAX 740 DEFIBRILLATOR IMPLANTED ON U.S. PATIENT
STUDY PUBLISHED IN JAMA CORROBORATES BIOMATRIX ™ REDUCES CARDIAC ACTIONS IN ACUTE MI PATIENTS WITH GREATER EFFICIENCY THAN A BARE-METAL STENT
MORTARA INSTRUMENT, INC. ANNOUNCES FDA CLEARANCE OF RSCRIBE 5 ELECTROCARDIOGRAPH SYSTEM WITHIN THE U.S.
FRESENIUS KABI PROCURES FENWAL HOLDINGS, INC.
SORIN GROUP DECLARES THE ACQUISITION OF CALIFORNIA MEDICAL LABORATORIES
EDWARDS INTUITY VALVE SYSTEM RECEIVES IDE FROM FDA TO BEGIN TRANSFORM TRIAL IN U.S.
SORIN GROUP ACQUIRES CALIFORNIA MEDICAL LABORATORIES (CALMED) FOR $14 MILLION.
SIEMENS LAUNCHES ACUSON P300 COMPACT PORTABLE ULTRASOUND SYSTEM.
THORATEC INTRODUCES THORATEC CONNECT™, THE FIRST CLOUD-BASED ADVANCED MCS PROGRAM MANAGEMENT SYSTEM
COVIDIEN ACQUIRES ORIDION SYSTEMS
DSM ACQUIRES KENSEY NASH.
BAYER INTRODUCES MEDRAD MARK 7 ARTERION® INJECTION SYSTEM.
SORIN GROUP AND ORANGE BUSINESS SERVICES INTRODUCE A REMOTE MONITORING SOLUTION FOR PATIENTS WITH IMPLANTED CARDIAC DEVICES IN EUROPE
SORIN GROUP AND ORANGE BUSINESS SERVICES LAUNCH REMOTE MONITORING SOLUTION FOR PATIENTS WITH IMPLANTED CARDIAC DEVICES IN EUROPE.
ENDOSENSE AND BIOTRONIK ANNOUNCE CE MARK APPROVAL FOR ENDOSENSE'S TACTICATH® QUARTZ FORCE-SENSING ABLATION CATHETER
IDEV TECHNOLOGIES INTRODUCES SUREPATH™ GUIDEWIRES
AORTECH POLYMERS HAVE A PIVOTAL ROLE IN MAQUET/AVALON LABS CONTRACT
IDEV TECHNOLOGIES COMPLETES ENROLLMENT OF SUPERB CLINICAL TRIAL
AORTECH INTRODUCES ISO CERTIFICATION
BIOSENSE WEBSTER LAUNCHES THERMOCOOL® SF NAV CATHETER WITH CURVE VISUALIZATION
VYGON TO FOCUS ON NEEDLE-FREE VASCULAR ACCESS STANDARDS AT THE WOCOVA 2012
FCC RULE FOR WIRELESS MEDICAL SENSOR TECHNOLOGIES
COOK MEDICAL LAUNCHES ZILVER® PTX® DRUG-ELUTING PERIPHERAL STENT IN AUSTRALIA
K-TUBE TECHNOLOGIES LAUNCHES NEW RESEARCH AND DEVELOPMENT PROCESS K-TUBE DISCOVER
MINDRAY MEDICAL RENEWS AGREEMENT WITH HEALTHTRUST PURCHASING GROUP, L.P. TO PROVIDE PATIENT MONITORING EQUIPMENT.
CRYOLIFE ACQUIRES HEMOSPHERE
COVIDIEN ACQUIRES SUPERDIMENSION, LTD.
BIOTRONIK UNVEILS REOCOR EXTERNAL PACEMAKER TO ITS EXTERNAL PRODUCT PORTFOLIO
FDA APPROVES BIOTRONIK'S NEXT GENERATION ICDS AND CRT-DS
PHILIPS LAUNCHES WIRELESS ARRHYTHMIA MONITORING SERVICE.
HEARTBEAT INTERNATIONAL AND BIOTRONIK ALLIANCE AGAINST CARDIOVASCULAR DISEASE IN MEXICO
SORIN GROUP DECLARES FDA SANCTION AND MARKET INTRODUCTION OF PARADYM™ RF ICDS AND CRT-D IMPLANTABLE HEART DEVICES
HEARTWARE COMPLETES ENROLLMENT IN ENDURANCE, THE PIVOTAL DESTINATION THERAPY CLINICAL TRIAL
SPECTOCOR UNVEILS POCKETECGTM, A COMPREHENSIVE MOBILE CARDIAC MONITORING
EDWARDS LIFESCIENCES ANNOUNCES CMS COVER FOR TRANSCATHETER HEART VALVE PROCEDURE
COVIDIEN TAKES OVER NEWPORT MEDICAL INSTRUMENTS
ASAHI KASEI ACQUIRES ZOLL
BIOTRONIK LAUNCHES THE EVIA HF-T, THE WORLD'S FIRST MRI-APPROVED CRT PACEMAKER
SPECTRANETICS OBTAINS FDA SANCTION FOR ADVANCED GLIDELIGHT TM LASER SHEATH
SOTERA WIRELESS' VISI MOBILE SYSTEM OBTAINS FDA 510(K) CLEARANCE
THORATEC E3XCEEDS 10,000 HEARTMATE II® IMPLANTS GLOBALLY
NEW TRIFECTA HEART VALVE LAUNCHED BY ST. JUDE MEDICAL IN JAPAN
COOK GROUP LAUNCHES COOK GENERAL BIOTECHNOLOGY
ABBOTT AND ST. JUDE MEDICAL FORM "CHOICE ALLIANCE" FOR CARDIOVASCULAR PRODUCTS IN THE UNITED STATES
ITL SIGNS AGREEMENT TO SELL MALAYSIAN DISTRIBUTOR
CARDICA APPLIES CE MARK FOR MICROCUTTER XCHANGE™ 30
REPORTS OF 87% REDUCTION IN CIED IMPLANT INFECTION WITH TYRX AIGISRX® ANTIBACTERIAL ENVELOPE
COVIDIEN SIGNS DEFINITIVE AGREEMENT TO ACQUIRE NEWPORT MEDICAL INSTRUMENTS
COVIDIEN SIGNS DEFINITIVE AGREEMENT TO ACQUIRE SUPERDIMENSION, LTD.
HELIOS EFFECTIVELY COMPLETES POSSESSION OF DAMP GROUP
TERUMO CARDIOVASCULAR SYSTEMS INKS AGREEMENT TO PURCHASE ORPHEUS HIGH-FIDELITY PERFUSION SIMULATOR TECHNOLOGY
COVIDIEN ACHIEVES FDA APPROVAL FOR PERIPHERAL VASCULAR STENT SYSTEM
ABBOTT'S STARLIMS BUSINESS ACQUIRES LONGTIME DISTRIBUTION PARTNERS
COOK MEDICAL BEGS PMDA APPROVAL FOR ZILVER® PTX® DRUG-ELUTING PERIPHERAL STENT IN JAPAN
SORIN GROUP LAUNCHES FIRST IMPLANT IN U.S. STUDY OF STENTLESS PERICARDIAL AORTIC VALVE
GREATBATCH ACQUIRES NEURONEXUS
SORIN GROUP DECLARES A FRESH AND FULL FOLDER OF PACING, DEFIBRILLATION AND LEFT VENTRICULAR LEADS
ENDOLOGIX ANNOUNCES ENROLLMENT OF FIRST PATIENT FOR VENTANA(TM) U.S. CLINICAL TRIAL
DIGIRAD RECEIVES CE MARK APPROVAL FOR CARDIUS(R) X-ACT IMAGING SYSTEM
SPECTRANETICS FORTIFIES PERIPHERAL VASCULAR FOLDER WITH AN AFFILIATION TO DISTRIBUTE THE TAPAS™ CATHETER
TERUMO CARDIOVASCULAR SYSTEMS TURNS EXCLUSIVE DISTRIBUTOR FOR TIGERPAW® SYSTEM II, LEFT ATRIAL APPENDAGE CLOSURE DEVICE
POSITRON ACQUISITION OF MANHATTAN ISOTOPE TECHNOLOGY
TERUMO AMERICAS HOLDING ACQUIRES ONSET MEDICAL CORPORATION, A PIONEER IN INNOVATIVE SHEATH TECHNOLOGY CRAFTED FOR MULTIPLE, MINIMALLY INVASIVE CLINICAL APPLICATIONS
COVIDIEN COMPLETES PURCHASE OF BÂRRX MEDICAL, INC.
MORTARA INSTRUMENT, INC. ACQUIRES DOLBY MEDICAL SALES AND SERVICE UK.
MAQUET CARDIOVASCULAR AND NOVADAQ SIGNED AGREEMENT TO DISTRIBUTE CO2 HEART LASER PRODUCTS
BIOTRONIK SUCCESSFULLY COMPLETES TESTING OF BIOTRONIK EHR DATASYNC®, WHICH CONNECTS BIOTRONIK HOME MONITORING® TO ELECTRONIC HEALTH RECORD SYSTEMS
BOSTON SCIENTIFIC UNVEILS CHARGER™ PTA BALLOON CATHETER.
ABBOTT INITIATES ESPIRIT I, CLINICAL TRIAL TO STUDY DRUG ELUTING BIORESORBABLE THERAPY FOR TREATMENT OF PAD
COVIDIEN ANNOUNCES DECISION TO SPIN-OFF PHARMACEUTICALS BUSINESS
C. R. BARD ACQUIRES LUTONIX
FDA APPROVES BERLIN HEART'S EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE (VAD).
ATTRIUS SYSTEMS RECEIVES HEALTH CANADA APPROVAL
BOSTON SCIENTIFIC RECEIVES FDA APPROVAL FOR THE INFINION™ 16 PERCUTANEOUS LEAD FOR PRECISION PLUS™ SCS SYSTEM.
BOSTON SCIENTIFIC LAUNCHES INDUSTRY-LEADING INCEPTA™ AND ENERGEN™ ICD AND CRT-D DEVICES WITH EXTENDED WARRANTIES
BOSTON SCIENTIFIC RECEIVES FDA APPROVAL FOR INCEPTA™, ENERGEN™ AND PUNCTUA™, THE NEW CRT-DS AND ICDS TO TREAT HEART FAILURE AND SUDDEN CARDIAC DEATH
BIOTRONIK INTRODUCES THE FIRST EVER IMPLANTABLE DEFIBRILLATORS ELIGIBLE FOR MAGNETIC RESONANCE IMAGING
FDA APPROVAL FOR PROMUS ELEMENT™ PLUS PLATINUM CHROMIUM STENT SYSTEM
COVIDIEN ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE BÂRRX MEDICAL, INC.
SECURITY AND EFFICIENCY: PACLITAXEL-ELUTING BALLOON SEQUENT® PLEASE DISPLAYS POSITIVE OUTCOME IN LARGEST REAL WORLD INTERNATIONAL REGISTRY
ROYAL PHILIPS ELECTRONICS LAUNCHES HEARTSTART FR3 IN US
TERUMO CARDIOVASCULAR SYSTEMS SIGNS DISTRIBUTION AGREEMENT WITH ESTECH FOR CABG PRODUCTS IN THE US
TERUMO CARDIOVASCULAR SYSTEMS TO SUPPLY ESTECH CABG PRODUCTS IN THE US
MEDTRONIC SEEKS FDA'S APPROVAL FOR ITS DRUG-ELUTING STENT (DES), RESOLUTE
BIOTRONIK PRESENTS NEW ECONOMIC MODEL
MEDTRONIC STARTS COREVALVE® SYSTEM'S TRAIL IN JAPAN
EDWARDS LIFESCIENCES RECEIVES THE US FDA APPROVAL FOR FIRST CATHETER-BASED AORTIC HEART VALVE
ABBOTT OBTAINS U.S. FDA APPROVAL FOR NEXT-GENERATION XIENCE PRIME™ DRUG ELUTING STENT
GETINGE ACQUIRES US-BASED ATRIUM MEDICAL INC
MEDTRONIC GAINS FDA'S APPROVAL FOR ASSURANT
MEDTRONIC FILES MODULAR PRE-MARKET APPROVAL APPLICATION FOR PHASED RF ABLATION SYSTEM TO TREAT PERSISTENT ATRIAL FIBRILLATION
COVIDIEN UNVEILS THE V-LOC PBT WOUND CLOSURE DEVICE
ST. JUDE MEDICAL RECEIVES FDA CLEARANCE FOR ILUMIEN™, THE FIRST AND ONLY COMBINED FFR AND OCT SYSTEM
C. R. BARD TO ACQUIRE MEDIVANCE
MULTIFOLD SECURITY: B. BRAUN MEDICAL INC. BROADCASTS INTROCAN SAFETY® 3 CLOSED IV CATHETER
SYNCARDIA SYSTEMS BECAME 'ARIZONA BIOSCIENCE COMPANY OF THE YEAR'
MEDTRONIC LAUNCHES NEXT-GENERATION CARDIOVASCULAR DEVICES IN JAPAN
CRYOLIFE PROVIDES UPDATE ON INVESTMENT IN VALVEXCHANGE®, INC.
SORIN GROUP INTRODUCES SONR® SENSOR BASED CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION SYSTEM
SORIN GROUP LAUNCHES SONR® CARDIAC RESYNCHRONIZATION THERAPY (CRT) OPTIMIZATION SYSTEM.
BOSTON SCIENTIFIC STARTS CLINICAL TRIAL ENROLLMENT FOR OMEGA™ PLATINUM CHROMIUM STENT SYSTEM
GETINGE GROUP ACQUIRES ATRIUM MEDICAL FOR $680 MILLION.
ST. JUDE MEDICAL UNVEILS SMALLER QUADRIPOLAR PACING SYSTEM IN EUROPE.
INSIGHT AGENTS GMBH RENAMED AGFA HEALTHCARE IMAGING AGENTS
AESCULAP, INC. PURCHASES ARAGON SURGICAL, INC.
BD UNVEILS BD INSYTE™ AUTOGUARD™ BC WITH BLOOD CONTROL TECHNOLOGY
MAQUET CARDIOVASCULAR RECEIVES FDA 510(K) CLEARANCE AND CE MARK FOR ITS NEW SENSATION PLUS™ 50CC 8 FR. INTRA-AORTIC BALLOON CATHETER
BIOTRONIK ANNOUNCES COMPLETION OF CLINICAL STUDY IN BIOLUX P-I FOR PERIPHERAL ARTERY DISEASE
COOK MEDICAL SEEKS FDA'S APPROVAL FOR ITS ZILVER® PTX® DRUG-ELUTING STENT
BOSTON SCIENTIFIC RELEASES COYOTE™ BALLOON CATHETER
COOK MEDICAL LAUNCHES ZILVER VENA VENOUS SELF-EXPANDING STENT IN EUROPE
AGFA HEALTHCARE SIGNS AGREEMENT TO ACQUIRE WPD
CENTURY MEDICAL TO DISTRIBUTE CARDICA'S MICROCUTTER PRODUCT LINE IN JAPAN
PATHWAY MEDICAL TECHNOLOGIES ACQUIRED BY MEDRAD, INC.
BOSTON SCIENTIFIC RECEIVES HEALTH CANADA APPROVAL FOR WALLFLEX® BILIARY RX STENT
FIRST U.S. IMPLANT OF ENDOLOGIX AFX ENDOVASCULAR AAA SYSTEM
THORATEC ACQUIRES MEDICAL BUSINESS OF LEVITRONIX
THORATEC REPORTS ACQUISITION OF MEDICAL BUSINESS OF LEVITRONIX
VICOR TECHNOLOGIES REPORTS AGREEMENT WITH ZOLL MEDICAL CORPORATION
BIOTRONIK COMPLETES BIOFLEX-I IDE CLINICAL TRIAL
ZOLL GRANTS EXCLUSIVE RIGHTS TO ASAHI KASEI TO DISTRIBUTE AED PLUS IN JAPAN
TRANSONIC SYSTEMS AND SCISENSE ANNOUNCE MERGER.
SAHAJANAND MEDICAL TECHNOLOGIES ACHIEVES CE APPROVAL FOR SUPRALIMUS® AND SUPRALIMUS-CORE®
ENDOLOGIX RECEIVES FDA APPROVAL FOR AFX ENDOVASCULAR AAA SYSTEM
MARYLAND MEDICAL CENTER'S PATIENT WITH ARTIFICIAL HEART GOT HEART TRANSPLANT
PULSION BECOMES PULSION MEDICAL SYSTEMS SE.
SUNSHINE HEART FULFILS FEASIBILITY STUDY FOR FULLY-IMPLANTABLE C-PULSE® HEART ASSIST SYSTEM
SPECTRANETICS LAUNCHES FOREMOST ADVANCED SYSTEM FOR SIMULATION OF PERIPHERAL VASCULAR ARTERIAL OCCLUSIONS
BOSTON SCIENTIFIC RECEIVES FDA APPROVAL AND LAUNCHES PROMUS® 2.25 MM EVEROLIMUS-ELUTING CORONARY STENT SYSTEM IN THE U.S.
ABBOTT GETS U.S. FDA APPROVAL FOR XIENCE NANO™ DRUG ELUTING STENT
CRYOLIFE COMPLETELY ACQUIRES CARDIOGENESIS
MEDRAD, INC. ANNOUNCES EUROPEAN APPROVAL AND LAUNCH OF THE COTAVANCE™ DRUG ELUTING BALLOON WITH PACCOCATH® TECHNOLOGY.
MAQUET RECEIVES CE MARK FOR MEGA® FAMILY OF INTRA-AORTIC CATHETERS
TERUMO AMERICAS HOLDING, INC. CONCURS TO ACQUIRE HARVEST TECHNOLOGIES CORPORATION, A PIONEER IN THE DEVELOPMENT OF POINT-OF-CARE CELLULAR THERAPY
BOSTON SCIENTIFIC ANNOUNCES INTERNATIONAL LAUNCH AND FIRST IMPLANTS OF ENERGEN™ AND PUNCTUA™
ADVANSOURCE BIOMATERIALS ENTERS INTO MULTI-YEAR SUPPLY AGREEMENT WITH AN INTERNATIONAL MEDICAL DIAGNOSTICS DEVICES COMPANY
SORIN GROUP ACQUIRES CE MARK SANCTION FOR PARADYM™ RF ICDS AND CRT-D
PARADYM™ RF ICDS AND CRT-D RECEIVES CE MARK APPROVAL
SORIN INRODUCES THE VASCUCLEAR™ ENDOSCOPIC VESSEL HARVESTING SYSTEM
EUROPEAN CE MARK CONSENT FOR ACCENT MRI (TM) PACEMAKER.
EXCOR® PEDIATRIC HDE APPLICATION IS OFFICIALLY UNDER REVIEW.
SORIN GROUP UNVEILS U.S. INTRODUCTION OF XTRA® AUTOTRANSFUSION SYSTEM
STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
BIOTRONIK ANNOUNCES US MARKET RELEASE OF SELECTRA, AN ADVANCED CRT LEAD DELIVERY SYSTEM
CRYOLIFE UNVEILS BIOGLUE(R) SURGICAL ADHESIVE IN JAPAN
BOSTON SCIENTIFIC ANNOUNCES FDA APPROVAL AND U.S. LAUNCH OF ION™ PLATINUM CHROMIUM STENT SYSTEM
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
NIHON KOHDEN LAUNCHES SALES SUBSIDIARY IN INDIA
HEARTWARE PRESENTS UPDATED DATA OF BTT CLINICAL TRIAL AND CONTINUED ACCESS PATIENTS
MEDTRONIC TO MERGE ITS U.S. CARDIAC AND VASCULAR GROUP SALES FUNCTIONS INTO A SINGLE ORGANIZATION
SPECTRANETICS DECLARES SANCTION OF LLD IN JAPAN
FDA APPROVED NEW BI-DIRECTIONAL ABLATION CATHETERS
MORTARA INSTRUMENT ACQUIRES TIBA MEDICAL'S BLOOD PRESSURE ASSETS.
AMERINET MEMBERS BENEFIT GREATLY AS MORTARA INSTRUMENT SIGNS CONTRACT WITH AMERINET.
HEARTWARE RECEIVES AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION (TGA) APPROVAL
MEDTRONIC BEGS FDA APPROVAL FOR CONSULTA® AND SYNCRA™ CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER (CRT-P) SYSTEMS
TERUMO CARDIOVASCULAR SYSTEMS ENTERS AGREEMENT ON TERMS OF CONSENT DECREE WITH FDA AS REGARDS QUALITY SYSTEM ADVANCEMENT
To order this report:
Cardiovascular_Devices Industry: Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article